How can we better support families living with cardiovascular disease and depression? by Jones, Martin et al.
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
‘This is the peer reviewed version of the following article: 
Martin Jones, David Thompson, Chantal Ski, Robyn Clark, 
Richard Gray, Kari Vallury, Ferdous Alam, (2016) "How can 
we better support families living with cardiovascular 
disease and depression?", The Journal of Mental Health 
Training, Education and Practice, Vol. 11 Issue: 1, 
pp.61-71, doi: 10.1108/JMHTEP-04-2015-0017
which has been published in final form at 
http://dx.doi.org/10.1108/JMHTEP-04-2015-0017
Copyright © Emerald Group Publishing Limited 2016
Journal 
Journal of Mental Health Training, Education and Practice 
Paper type 
Conceptual paper 
Title 
How can we better support families living with cardiovascular disease and depression? 
Authors 
Martin Jones (Department of Rural Health, University of South Australia, Whyalla, Australia) 
David Thompson (Cardiovascular Research Centre, Australian Catholic University, Sydney, Australia 
AND Department of Psychiatry, University of Melbourne, Melbourne, Australia AND Department of 
Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia) 
Chantal Ski (Cardiovascular Research Centre, Australian Catholic University, Sydney, Australia AND 
Department of Psychiatry, University of Melbourne, Melbourne, Australia) 
Robyn Clark (School of Nursing and Midwifery, Flinders University, Adelaide, Australia) 
Richard Gray (Hamad Medical Corporation, Doha, Qatar) 
Kari Vallury (Department of Rural Health, University of South Australia, Adelaide, Australia) 
Ferdous Alam (Department of Cardiology, Whyalla Hospital and Health Services, Whyalla, Australia) 
Corresponding author  
Martin Jones can be contacted at: martin.jones@unisa.edu.au 
Abstract 
Purpose 
The purpose of this paper is to discuss the role of psychosocial treatments to support families living 
with cardiovascular disease (CVD) and depression. The paper highlights that depression in people 
with CVD is a predictor of non-adherence to both medicines and cardiovascular rehabilitation 
programmes. The authors believe there is a clinical need to develop a programme of care to support 
the whole family to adhere to cardiovascular rehabilitation programmes.  
Design/methodology/approach 
A team of expert cardiovascular nurses, mental health nurses (MHN) and cardiologist clinical opinions 
and experiences. These opinions and experiences were supplemented by literature using MEDLINE 
as the primary database for papers published between December 2000 and December 2013.  
Findings 
People with CVD who become depressed are more likely to stop taking their medicine and stop 
working with their health care worker. Most people with heart and mood problems live with their 
families. Health workers could have a role in supporting families living with heart and mood problems 
to their care and treatment. The paper has highlighted the importance of working with families living 
with heart and mood problems to help them to stick with care and treatment.  
Originality/value 
Most people with heart and mood problems live with their families. The paper has highlighted the 
importance of working with families living with heart and mood problems to help them to persevere 
with care and treatment. MHN may have a role, though consideration should also be given to 
exploring the role of other health care workers and members of the community. As the population 
ages, clinicians and communities will need to consider the impact of depression on adherence when 
working with families living with CVD and depression. 
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1. Introduction  
Cardiovascular disease (CVD) and depression are significant global health issues. CVD is the leading 
cause of death worldwide, with 30 per cent of global deaths being attributed to CVD (World Health 
Organisation, 2013). CVD or coronary artery disease is a leading cause of death, whereby one 
Australian dies approximately every 12 minutes from an associated disease (Heart Foundation, 
2013). CVD includes diseases such as angina, heart failure and hypertension, but also includes 
events such as a myocardial infarction (MI) (World Health Organisation, 2010).  
 
Depression is the leading cause of disability, affecting approximately 350 million people worldwide 
(World Health Organisation, 2012). There is substantial evidence for identifying depressive symptoms 
in patients with CVD and MI (Colquhoun et al., 2013). Approximately 15-20 per cent of post-MI 
patients become depressed in the year following the MI event (Colquhoun et al., 2013; Lesperance et 
al., 1996).  
 
The two conditions appear to be interlinked (Lichtman et al., 2008). The impact of major depressive 
disorder on CVD is similar to that of smoking and physical inactivity (Ye et al., 2013).  
 
Major depression is a well-established risk factor for developing CVD (Heart Foundation, 2014; 
Colquhoun et al., 2013). Patients with major depression have been identified as having an increased 
risk of developing CVD (Carney et al., 1988; Lichtman et al., 2008). People living with depression and 
CVD will die earlier and have higher levels of disability than people with CVD who do not become 
depressed (Carney and Freedland, 2003; Frasure-Smith and Lesperance, 2008; Zellweger et al., 
2004). This results in greater use of health services with consequently increased costs (Heart 
Foundation, 2013; Frasure-Smith and Lesperance, 2008).  
 
Our paper discusses the potential benefits of developing family-based treatments for families living 
with CVD and depression to aid adherence to care and treatment in which mental health nursing 
(MHN) may have a role.  
 
2. Data sources and scoping review process  
As a group of clinical academics in the field of MHN, Cardiac-Vascular Nursing and Cardiology we are 
interested as to how we can better support people living with CVD and depression. All of us believe 
that clinicians need to do better in helping people living with CVD and depression to adhere with 
treatment in particular cardiovascular rehabilitation programmes. As a team of experienced clinical 
academics we have observed the important role families have in providing ongoing support for people 
living with long-term conditions. We believe that families play a crucial role in helping people living 
with CVD and depression to adhere with cardiovascular rehabilitation programmes. We also believe 
that clinicians could be prepared to work more effectively with families living with CVD and depression 
to empower them to adhere with cardiovascular treatment regimes. Greater adherence to treatment 
may improve cardiovascular health, improve depression, increase quality of life and reduce mortality 
rates. In addition MJ believes MHN or suitably trained mental health clinicians could have a role in 
supporting other clinicians to practice this approach. These beliefs have informed our meetings, 
guided our search and helped us to understand the literature. In these meetings we have reflected 
upon the following:  
1. the reasons for high prevalence of depression in people living with CVD;  
2. non-adherence in people living with CVD and depression;  
3. psychosocial approaches to supporting people living with CVD and depression;  
4. working with families living with CVD and depression to adhere to care and treatment;  
5. the potential role of MHN in operationalising family interventions for families living with CVD 
and depression; and  
6. future research priorities.  
 
Our beliefs were supplemented by a preliminary search of the literature to help us reflect on how we 
can support families living with CVD and depression to adhere to treatment.  
 
One of the tasks of our group was to agree on the areas to search. We included studies which 
reported strategies aimed at improving the health and well-being of people living with CVD and 
depression. We were interested if papers reported clinically meaningful improvements in depression 
and cardiovascular health through working with the family living with CVD and depression. We also 
included papers which described models of care to support practitioners to work with people living 
with depression and CVD. The purpose of this exercise was not to conduct a systematic review, but 
as senior clinicians to assist others to reflect upon new ways of working with a clinical problem which 
will increase in both severity and prevalence.  
 
We identified studies through a search of the MEDLINE database for papers published between 
December 2000 and December 2013. The search strategy included a combination of key words and 
MeSH headings using variations of CVD, Depression, Family Support and Adherence. The initial 
search yielded 103 papers. MJ reviewed the titles, and then read the abstracts against the inclusion 
criteria, before selecting the final papers for presentation to the group. We identified 14, consisting of 
opinion articles, cohort studies, randomised controlled trials and meta-analyses.  
 
See list below for search terms, Table I for inclusion and exclusion criteria and Table II for a list of 
included articles.  
 
Used search strategies for MEDLINE:  
 Families, Cardiac-Vascular Disease, Depression, Adherence; or  
 Carers, CVD, Depression, Adherence; or  
 Family Support; or  
 Family Interventions; or  
 Adherence Therapy.  
 
3. Why do people with CVD become depressed?  
3.1. Biological mechanisms  
We have yet to fully understand the mechanisms that underpin the relationship between CVD and 
depression. In our practice we have observed that depression and CVD will continue to impact upon 
one another through the complex interaction between pathophysiological, psychological and 
psychosocial factors, as illustrated in Figure 1.  
 
In our interpretation of the literature we have noted a number of biological factors associated with 
CVD appear to be linked with depression which supports our observations from clinical practice. 
People with depression may have a lower response to stress (Taylor et al., 2006). This can result in 
increased inflammation and sympathetic activity impacting upon cardiovascular health (Kunz-Ebrecht 
et al., 2003). Increased sympathetic activity results in catecholamine release, ischaemic damage and 
oxidative stress (Adameova et al., 2009). An increase in platelet activation (Musselman et al., 1996), 
ventricular tachycardia (Carney et al., 1993) and C-reactive protein and other inflammatory markers 
(Lesperance et al., 2004) have all been associated with depression as a risk factor for CVD (Rugulies, 
2002).  
 
3.2. Psychosocial variables  
Our experience of working with people with people living with CVD is that a diagnosis of any CVD is a 
significant life event, inevitably impacting upon patient psychological well-being (Stanton et al., 2007). 
We have observed in our practice that grief and loss are experienced as the person adapts to living 
with a long-term condition. A CVD event may induce feelings of grief and loss. Pain is associated with 
depression and advancing illness may induce feelings of helplessness. Our clinical observations are 
that these experiences trigger anxiety and stress which may further impact upon the cardiovascular 
system (Hughes et al., 2004; Taylor et al., 2006). Our clinical observations are supported by the 
literature. Glozier et al. (2013) conducted a review of psychosocial stressors and CVD. The review 
identified that psychosocial stressors such as job strain, shift work and social isolation following a 
CVD event are associated with increased CVD events.  
 
As clinicians, we have observed how chronic illness can interfere with a patient's familiar lifestyle 
through changes to family, work and social factors. We have seen how status is lost as illness 
restricts pleasurable activities the patient was once was involved in. Through our experience of 
working with families we have observed that the dynamics within a family are altered as someone 
responsible for household tasks may become dependent on others for care. CVD and depression can 
have substantial economic impacts on families with costs associated with utilisation of emergency and 
hospital services as well as loss of productivity because of reduced employment prospects (Rodwin et 
al., 2013). Such losses can affect a patient's functioning and could lead to the onset of depressive 
symptoms and subsequently poorer health outcomes among patients with CVD (Stanton et al., 2007). 
Patients who do not positively adapt to CVD have been shown to have an increased risk of CVD 
complications as well as developing depressive symptoms (McLaughlin et al., 2005).  
 
A psychosocial factor is a phenomenon involving the interaction of a person's social environment with 
their psychology and its effects on medical pathology (Hemingway and Marmot, 1999). Smoking and 
nicotine dependence, for example, has increased prevalence among depressed individuals 
(Fergusson et al., 2003), which is a known independent risk factor for CVD (Heart Foundation, 2014). 
Lack of social support and an unmarried marital status have also been directly linked to depression 
and CVD (Compare et al., 2013). Our interpretation of the literature and clinical experiences has 
helped us to reflect how health services are organised to support people living with CVD and 
depression. We have come to the view that the organisation of health services does not support the 
integration of treatment approaches to manage people suffering from CVD and depression. A 
psychiatrist who has an expertise in treating depression will not necessarily have the same expertise 
in treating CVD.  
 
4. Non-adherence in patients with comorbid depression  
Our clinical experience of providing care and treatment to people who have struggled to adhere to 
care and treatment informs us that non-adherence results in poor health outcomes (DiMatteo et al., 
2000). Increasing severity of depression can be linked to non-adherence among individuals with the 
comorbid diseases (Rieckmann et al., 2006; Gehi et al., 2005). We are not surprised that depressed 
patients are approximately three times less likely than non-depressed patients to be treatment 
adherent, including medication, dietary advice and health behaviours (DiMatteo et al., 2000; 
Rieckmann et al., 2006). Depressed patients take medication on fewer days each week (Carney et 
al., 1995), skip more doses, forget to take the medication or do not take it as prescribed (Gehi et al., 
2005). Depression has been linked to significantly reduced adherence to blood pressure lowering 
(Aggarwal and Mosca, 2010) and aspirin medication regimes in CVD patients (Rieckmann et al., 
2006). Treatment adherence can also impact on family dynamics, hopelessness and lack of social 
support (DiMatteo, 2004). Non-adherence with care and treatment may also exacerbate the effect of 
depression on CVD (Gehi et al., 2005). We have taken the view that the cycle of treatment non-
adherence in CVD and depression could be addressed by working with underlying psychosocial and 
clinical factors (DiMatteo et al., 2000).  
 
5. Psychosocial approaches to supporting people living with CVD and depression  
Our clinical observations are that when psychological care is provided to people living with CVD and 
depression, then the patients' health and well-being tends to improve. Reid et al., (2013) in a 
systematic review of the effectiveness of psychosocial interventions for families living with CVD and 
depression identified a number of health-related areas such as improved quality of life, reduction in 
blood pressure and satisfaction with the care experience. However, there was no impact on mortality, 
morbidity or other cardiovascular risk factors.  
 
Promising evidence has emerged regarding the application of psychosocial treatment approaches to 
supporting patients with CVD and depression. The Improving Mood Promoting Access to 
Collaborative Care Treatment (IMPACT) collaborative care model has been established as an 
effective means of delivering care for patients with depression (Hunkeler et al., 2006). Collaborative 
care involves multiple components which monitor chronic disease and associated risk factors (Morgan 
et al., 2009). This model involves a team of health professionals in the service delivery, including a 
depression care manager, the patient's primary general practitioner (GP), a consulting psychiatrist, as 
well as a consulting GP. This approach saw significant improvements for patients in treatment 
adherence, depressive symptoms, physical functioning and quality of life (Morgan et al., 2013). The 
TrueBlue study built on IMPACT to apply the collaborative care model for patients with comorbid 
depression and chronic disease such as diabetes or heart disease (Morgan et al., 2013). This study 
utilised practice nurses in general practice settings to assist in screening and monitoring 
physiological, mental health and lifestyle risks associated with these particular chronic diseases. This 
study provides an opportunity to modify the intervention for those living with depression and CVD. 
However, the research focused on the individual patient rather than working with the whole family and 
has not used approaches which have helped people to adhere to care and treatment.  
 
We identified two randomised controlled trials which adopted a telephone coaching technique to help 
patients with CVD to take control of their care and treatment (Vale et al., 2002, 2003). The aim of the 
coaching intervention was to increase adherence to drug therapy and diet. The primary outcome 
measure was fasting serum total cholesterol (TC), serum triglyceride, high-density lipoprotein 
cholesterol and calculated low-density lipoprotein cholesterol (LDL-C). After six months, the patients 
in the coaching arm of the study had significantly lower mean TC and LDL-C levels.  
 
Cognitive Behavioural Therapy (CBT) may be a successful intervention for helping people who live 
with a long-term condition to adhere to treatment and care. We identified a cohort study which 
improved treatment adherence in depressed patients with other chronic diseases using the principles 
of CBT (Cukor et al., 2014).  
 
6. Working with families living with CVD and depression  
We would take the view that a programme of care should have a strong focus on enabling families to 
take control of their treatment. This should focus upon, supporting the family to develop their problem 
skills, reflect upon previous experiences and make active plans for the future in the area of their care 
and treatment. The inclusion of family members in helping patients to adhere to care and treatment 
for depression and CVD is in our clinical experience an area in which clinicians should consider 
developing. Helping patients cope with and adjust to the challenges of living with a long-term 
condition can have positive impacts on emotional and physical health (Karademas and Hondronikola, 
2010). Reid et al.'s (2013) systematic review has argued that there is a need to conduct research 
which may demonstrate the effectiveness of working with families. Ski and Thompson (2011) add to 
this, outlining that psychosocial intervention should be integrated across the different care pathways.  
 
Pharaoh et al. (2012) in a meta-analysis identified that working with families living with schizophrenia 
may reduce the risk of relapse and help adherence with medication. The core principles of an 
effective family approach are ongoing contact with a health care professional, usually of three months 
to a year. The family is provided with an opportunity to have at least ten sessions with a suitably 
trained practitioner. Each session focuses upon information about the condition and treatment 
options, which includes developing problem solving skills and what to do in a crisis. In the UK 
guidelines for working with families living with serious mental illness (SMI) have been incorporated 
into national guidelines to inform mental health care services (National Institute of Clinical Excellence, 
2014). We believe the principles underpinning family work with people with SMI could be applied to 
depressed individuals and families living with CVD. In a systematic review of the effectiveness of 
working with families living with stroke and depression, a number of commonalities with the 
schizophrenia literature were identified. The studies which adopted the principles of working with 
families living with schizophrenia demonstrated clinically meaningful improvements (Vallury et al., 
2015).  
 
No research has evaluated the impact of working with families living with CVD and depression in 
supporting adherence to treatment.  
 
7. Should MHN have a role in operationalising family interventions for families living with CVD 
and depression?  
MHN in the UK has played a strong and purposeful role in preparing mental health professionals to 
work purposefully with families living with SMI (Brooker, 2001). Consequently large numbers of MHN 
in the UK have been prepared to work with families living with SMI. In addition, initiatives to implement 
evidence-based psychosocial interventions have demonstrated worthwhile improvements for both 
staff and patients (Brown et al., 2013). It is for these reasons that one member of the team (MJ) 
believes MHN may have a role in developing short and concise training programmes in this area to 
support other health care professionals. These would prepare professionals to combine psychosocial 
interventions with physical health care into an integrated care pathway. In addition MHN could provide 
supervision and support and assist services regarding the required structures needed to sustain 
changes in clinical practice. MHN is arguably the professional group that has had the greatest 
exposure to adherence training programmes in conditions such as schizophrenia. They may have a 
role in helping families to adhere to complex treatment regimens. Other members of the team have 
expressed a degree of caution and believe that MHN may not necessarily be the best fit for this role. 
All of the team are of the view that further discussion is required as to whether other health care 
workers or people with lived experience or volunteers could have a role in supporting families living 
with CVD and depression.  
 
8. Limitation of conceptual paper and future research priorities  
We hold largely positive views about the benefits of working with families living with CVD and 
depression to help them to adhere with cardiovascular rehabilitation programmes. This may have 
introduced a degree of bias into our interpretation of the literature. In addition only a relatively small 
number of papers reported clinically meaningful in patients' health and well-being. Thus our 
conclusions for further research are based on our clinical opinions with limited support from the 
literature we searched. So where does this leave us regarding future research priorities in this area? 
We would argue that as a priority a systematic review is required to help us understand the impact of 
family interventions on the outcomes for people with CVD and depression, and their family. It would 
help us to understand which characteristics of the intervention are effective and their suitability for 
clinical practice, to understand future workforce training needs and to plan future research priorities. 
Ultimately any model which emerges will require a workforce able to implement it. High professional 
self-esteem and positive attitudes about therapeutic impact are generally recognised as a key 
ingredient in sustaining changes in the work environment (Jones et al., 2008; Jones and Lancashire, 
2009). Studies evaluating staff attitudes to recovery from CVD and depression may help health 
providers understand what strategies need to be put in place to prepare staff to practise in this area.  
 
A programme of research would require extensive consultation both with families living with CVD and 
depression and the health care workers. This would help us to understand the experiences of families 
and how we could get better at working with the whole family. As experienced clinicians we would 
argue that research is required to help us understand the potential barriers to working with families 
and to find solutions to overcome the barriers in the practice settings. This may include the need to 
ensure that support structures are in place to reduce the potential negative impact of working with the 
family on workplace morale. We would then be able to evaluate the impact of enabling families living 
with depression and CVD to adhere to care and treatment and consequent improvements in both 
mental and physical health.  
 
9. Conclusion  
CVD and major depressive disorder are highly prevalent, with both mentioned in the top three leading 
causes of morbidity and mortality (Begg et al., 2008). Depression is a risk factor for the development 
and exacerbation of CVD and vice versa (Heart Foundation, 2014; Lesperance et al., 1996). The 
association between the two diseases is complex. Living with a long-term condition and depression 
predicts non-adherence (DiMatteo et al., 2000). A family-based intervention aimed at supporting the 
family could lead to increased adherence and ultimately more positive outcomes. MHN may have 
both a clinical leadership and research role in this process in supporting other health care 
professionals to better support families living with CVD and depression. Depression and CVD will 
become an increasingly common clinical problem as our population ages. Clinicians will need to 
increasingly focus on the impact of depression on adherence for people living with CVD. At the same 
time, there are exciting opportunities to develop models of care to support families that may alleviate 
the distress and disability associated with living with CVD and depression.  
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Figure 1 The vicious cycle of depression and cardiovascular disease  
 
 
  
Table I Inclusion and exclusion criteria 
Inclusion criteria Exclusion Criteria 
Peer-reviewed papers related to families living 
with CVD and depression and interventions to 
help families living with a long-term physical 
condition and depression to adhere to treatment 
Peer-reviewed papers that did not focus on the 
role of services in supporting the family living 
with CVD and depression 
 
  
Table II Summary 
Author Study Outcome 
1. Rieckmann  
et al. (2006) 
Medication monitoring used to measure 
adherence to aspirin with the primary 
aim to assess whether depression 
severity impacts upon adherence 
Depression severity is associated 
with increased non-adherence 
2. Gehi et al. 
(2005) 
Cohort study examining the association 
between major depression and self-
reported medication adherence 
Twice as many depressed 
participants as non-depressed 
participants reported forgetting to 
take their medication 
3. DiMatteo 
(2004) 
Meta-analysis Risk of non-adherences increases in 
people with long-term condition 
4. DiMatteo  
et al. (2000) 
Meta-analysis Depressed patients three times more 
likely to be non-adherent than non-
depressed patients 
5. Morgan et al. 
(2013) 
Two-arm open randomised controlled 
trial to assess the effect of preparing 
practice nurses to be case managers 
for people with depression and long-
term conditions 
Improvement in depression and 
increased adherence to treatment 
guidelines 
6. Vale et al. 
(2002) 
RCT to test the effectiveness of 
coaching to assist patients with CVD to 
take control of their treatment 
Reduction in serum cholesterol levels 
in the coaching arm of the study 
7. Vale et al. 
(2003) 
Multi-centre RCT to test the 
effectiveness of coaching in reducing 
cholesterol 
Reductions in patient cholesterol 
level 
8. Karademas 
and 
Hondronikola 
(2010) 
Prospective study in sample of cardiac 
patients 
Adjustment support aids health and 
well-being 
9. Reid et al. 
(20130 
Systematic review Psychological interventions may 
improve health-related quality of life 
10. Ski and 
Thompson 
(2011) 
Review paper Primary care teams need to integrate 
both physical health and 
psychosocial interventions into a 
single pathway 
11. Cukor et al. 
(2014) 
Cohort study assessing the efficacy of 
CBT in haemodialysis patients 
Improvements in prescription 
adherence 
12. Hunkeler  
et al. (2006) 
Two-arm randomised controlled trial 
assessing the long-term effects of case 
management 
Patients in the treatment arm are 
more likely to adhere to treatment 
13. Aggarwal 
and Mosca 
(2010) 
Cross-sectional study to determine the 
prevalence and predictors of non-
adherence to anti-hypertensives and 
statins 
Depression is significant determinant 
of non-adherence 
 
